Average Co-Inventor Count = 12.38
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Janssen Pharmaceutica Nv (9 from 2,078 patents)
2. Janssen Sciences Ireland Unlimited Company (3 from 61 patents)
3. Janssen Biotech, Inc. (1 from 410 patents)
4. Novartis Ag (3,923 patents)
13 patents:
1. 12275770 - Glucagon like peptide 1 (GLP1)-growth differentiation factor 15 (GDF15) fusion proteins and uses thereof
2. 12134636 - Immunoglobulins and uses thereof
3. 11767354 - Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
4. 11713345 - Glucagon like peptide 1 (GLP1)-growth differentiation factor 15 (GDF15) fusion proteins and uses thereof
5. 11591379 - Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
6. 11401315 - Immunoglobulins and uses thereof
7. 11208464 - GDF15 fusion proteins and uses thereof
8. 10968265 - Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
9. 10858413 - Immunoglobulins and uses thereof
10. 10787495 - Immunoglobulins and uses thereof
11. 10640544 - Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
12. 10428134 - Immunoglobulins and uses thereof
13. 10336812 - GDF15 fusion proteins and uses thereof